Publisher correction: Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease
Research output: Contribution to journal › Comment/debate › peer-review
Authors
Colleges, School and Institutes
External organisations
- BRIGHAM AND WOMEN'S HOSPITAL
- Southeast University
- Harvard Medical School, Wellman Center for Photomedicine, Massachusetts General Hospital
- University of Sydney, Austria;
- Garvan Institute of Medical Research
- University of New South Wales (UNSW) Australia
- German Center for Neurodegenerative Diseases
- Mayo Clinic Scottsdale-Phoenix, Arizona
- McLean Hospital
- University of Auckland
- University of Kentucky
- Banner Sun Health Research Institute
- Harvard Medical School
Abstract
Correction to: Nature Neuroscience https://doi.org/10.1038/s41593-018-0223-0, published online 17 September 2018.
In the version of this article initially published, the legends for Supplementary Figs. 4–8 and 10–14 contained errors. The Supplementary Figure legends have been corrected in the HTML and PDF versions of the article.
Details
| Original language | English |
|---|---|
| Pages (from-to) | 144-147 |
| Number of pages | 4 |
| Journal | Nature Neuroscience |
| Volume | 22 |
| Issue number | 1 |
| Publication status | Published - 17 Dec 2018 |